Evofem Biosciences, Inc. (EVFM) › Total AssetsEvofem Biosciences, Inc. (EVFM) — Total AssetsAnnual figures by fiscal year, from SEC filings.2014: $76.90M2015: $40.11M2016: $12.82M2017: $3.95M2018: $4.01M2019: $28.30M2020: $109.97M2021: $42.51M2022: $25.16M2023: $10.55M2024: $23.79M2025: $20.27M$20.27M2014Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$20.27M-14.8%2024$23.79M+125.4%2023$10.55M-58.1%2022$25.16M-40.8%2021$42.51M-61.3%2020$109.97M+288.6%2019$28.30M+605.6%2018$4.01M+1.5%2017$3.95M-69.2%2016$12.82M-68.0%2015$40.11M-47.8%2014$76.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share